S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including C3.ai, Collegium Pharmaceutical, ChargePoint Holdings, S&P Global, Dollar Tree, Novartis, Core & Main, EVERTEC, Celanese, and StoneCo. Notable changes include a significant downgrade for Dollar Tree and a raised target for S&P Global.

September 05, 2024 | 12:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler cut the price target for C3.ai from $29 to $24, maintaining a Neutral rating. Shares fell 1.9% to $23.01.
The price target cut suggests a bearish outlook, which likely contributed to the 1.9% drop in share price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Piper Sandler cut Celanese's price target from $180 to $150, downgrading from Overweight to Neutral. Shares fell 0.8% to $124.31.
The price target cut and downgrade to Neutral indicate negative sentiment, contributing to the share price decline.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Needham cut ChargePoint's price target from $3 to $2, maintaining a Buy rating. Shares fell 0.6% to $1.69.
The price target cut suggests a bearish outlook, despite the maintained Buy rating, leading to a slight share price decline.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Baird cut Core & Main's price target from $62 to $53, maintaining an Outperform rating. Shares fell 15.8% to $39.40.
The price target cut, despite the maintained Outperform rating, suggests negative sentiment, leading to a significant share price drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEGATIVE IMPACT
BMO Capital cut Dollar Tree's price target from $130 to $68, downgrading from Outperform to Market Perform. Shares fell 22.2% to $63.56.
The significant price target cut and downgrade led to a sharp 22.2% decline in share price, indicating strong negative sentiment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 90
NEGATIVE IMPACT
Susquehanna slashed EVERTEC's price target from $38 to $28, downgrading from Neutral to Negative. Shares rose 0.3% to $33.73.
The significant price target cut and downgrade to Negative suggest bearish sentiment, though shares saw a slight increase.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Morgan Stanley lowered StoneCo's price target from $16.5 to $7, downgrading from Equal-Weight to Underweight. Shares fell 3.8% to $12.61.
The drastic price target cut and downgrade to Underweight suggest strong negative sentiment, leading to a notable share price drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
NEUTRAL IMPACT
Goldman Sachs raised Novartis' price target from $119 to $121, downgrading from Buy to Neutral. Shares rose 0.7% to $119.38.
The slight price target increase and downgrade to Neutral suggest mixed sentiment, resulting in a modest share price rise.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
HC Wainwright & Co. raised the price target for Collegium Pharmaceutical from $47 to $50, maintaining a Buy rating. Shares gained 2.2% to $38.24.
The raised price target and maintained Buy rating indicate positive sentiment, reflected in the 2.2% share price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Morgan Stanley raised S&P Global's price target from $530 to $564, maintaining an Overweight rating. Shares gained 0.5% to $513.31.
The raised price target and maintained Overweight rating indicate strong positive sentiment, contributing to the share price increase.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90